V
Exchange
UNKNOWN
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Market Data
$0.01+$0.00 (+8.33%)
VINC · Last trade
Prev Close
$0.01
Range (29d)
$0.01 – $0.01
Recent Filings
- 8-K161.6 KBVincerx Pharma, Inc.Jul 7, 4:23 PM ET·0001193125-25-156210
- 10-Q3.8 MBVincerx Pharma, Inc.May 15, 4:00 PM ET·0001193125-25-120762
- 8-K199.0 KBVincerx Pharma, Inc.Apr 17, 4:52 PM ET·0001193125-25-084406
- 8-K147.4 KBVincerx Pharma, Inc.Apr 11, 4:03 PM ET·0001193125-25-079090
- 10-K9.0 MBVincerx Pharma, Inc.Mar 27, 4:01 PM ET·0001193125-25-065487
- 8-K256.7 KBVincerx Pharma, Inc.Mar 18, 9:02 AM ET·0001193125-25-056229
- 8-K163.1 KBVincerx Pharma, Inc.Feb 28, 4:10 PM ET·0001193125-25-042484
- 8-K142.8 KBVincerx Pharma, Inc.Feb 18, 4:03 PM ET·0001193125-25-028591
- 8-K172.4 KBVincerx Pharma, Inc.Feb 6, 4:05 PM ET·0001193125-25-021771
- 8-K8.6 MBVincerx Pharma, Inc.Jan 23, 4:13 PM ET·0001193125-25-011457
Insiders
10- Bushnell Laura I.Director
- Byrd John C.10% Owner
- Dennis BarryDirector
- Dobkin DavidDirector, Chief Financial Officer
- Druker BrianDirector
- Garban Hermes de JesusChief Medical Officer
- GROSSMAN JONASDirector, 10% Owner
- Haas KevinActing Chief Financial Officer
- Hamdy Ahmed MDDirector, President and CEO, 10% Owner
- Hwang SooinChief Business Officer
Tickers
- VINCUNKNOWN
Addresses
business
260 SHERIDAN AVENUE SUITE 400
PALO ALTO, CA, 94306
mailing
260 SHERIDAN AVENUE SUITE 400
PALO ALTO, CA, 94306
Former Names
- Vincera Pharma, Inc.2021-01-05
- LifeSci Acquisition Corp.2020-12-22